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Abstract
Introduction: Sample stability can be influenced by many different factors; evaporation and leakage from residual cells are the most relevant 
factors for electrolytes. During the analytical phase, samples are usually kept uncapped at room temperature. Once samples are processed, they are 
usually stored sealed and refrigerated. Long turnaround time and the possibility of “add-on test” need consideration for electrolyte stability. The 
aim of our study is to examine short-term electrolyte stability in this two-common laboratory working conditions in two different lithium heparin 
plasma tubes (Barricor and PST II, Becton Dickinson). 
Materials and methods: In 39 plasma samples from voluntary subjects we measured sodium (Na+), potassium (K+) and chloride (Cl–) at 6 time po-
ints since centrifugation (0h, 3h, 6h, 9h, 12h and 15h). Maximum allowable bias (clinically significant change) was based in SEQC (Sociedad Española 
de Química Clínica) recommendations; 1% for Cl–, 0.6% for Na+ and 4% for K+.
Results: In open room temperature tubes, clinically significant changes appeared in Na+ and Cl– after 3 hours and in K+ after 9 hours in both types 
of tubes. In refrigerated sealed tubes, all the analytes were clinically stable up to 12 hours in both kinds of plasma tubes. We observed a statistically 
significant progressive increase in K+ levels, which was less pronounced in Barricor tubes.
Conclusion: Stability of electrolytes is compromised after 3 hours in open tubes and after 12 hours in sealed tubes.
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Short Communication
Introduction
Many factors are known to influence stability. 
Evaporation is a well-known cause of variation in 
analyte concentration, especially in automated en-
vironments (1), influenced by sample volume, tube 
type, storage conditions and surface area (2). Stor-
age temperature is also recognized as a significant 
factor in sample stability, particularly for potassi-
um (K+); at low temperatures, the Na+/K+ ATPase is 
inhibited and K+ tends to leave the cells (3).
Plasma samples are used in many emergency lab-
oratories because of the shorter turn-around times 
when compared to serum. However, it is tradition-
ally acknowledged that serum is more stable for 
some analytes probably due to the presence of 
less residual blood cells (4). In serum tubes, gel 
flows upwards easily and smoothly during centrif-
ugation and thus traps cells below. In plasma 
tubes with gel separator, more residual cells are 
found in the upper layer affecting stability of elec-
trolytes or glucose. 
BD® Barricor is a new tube designed to obtain sta-
ble plasma that contains a barrel-shaped polymer 
as mechanical separator. During the whole centrif-
ugation time cells flow downwards between the 
separator and the tube walls, obtaining plasma 
with less residual cells (5). After centrifugation, the 
polymer due to its properties, returns to its origi-
nal shape and is positioned tightly separating 
plasma from the erythrocytes and the buffy-coat. 
This is meant to increase plasma stability with re-
spect to gel based tubes.
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The aim of this study was to examine sodium (Na+), 
potassium (K+) and chloride (Cl-) stability in PST™ II 
lithium heparin tubes and Barricor lithium heparin 
tubes in different storage conditions and time pe-
riods. 
Materials and methods
This prospective study was conducted over three 
different days of the same month in the ISO:15189 
certified Emergency Laboratory of our tertiary 
care centre (Hospital Universitario la Paz, Madrid). 
Analysis was performed in a Siemens Dimension 
Vista® 1500 analyser (Siemens Healthineers, Erlang, 
Germany) as per manufacturer specifications with 
an indirect ion selective electrode (V-LYTE® Inte-
grated Multisensor Technology, Siemens Health-
ineers, Erlang, Germany, REF K800A) for measuring 
the three ions. Quality control material was run for 
electrolytes every 12 hours (Liquid Assayed Multi-
qual, Bio-Rad, Hercules, California), following our 
quality assurance procedures, and remained in 
range during the study.
Two storage conditions were chosen as they are 
the most commonly used in laboratory routine 
during processing (open and room temperature 
(rt)) and storage (sealed and refrigerated). Only 
healthy volunteers participated in this study and 
they were subdivided in 4 groups, which were not 
intended to be compared specifically among each 
other; Barricor open - rt, Barricor sealed - 4 ºC, PST 
II open - rt and PST II sealed - 4 ºC.
We defined a priori exclusion criteria consisting of 
lack of proper consent, current treatment for ma-
lignancy, terminal illness or receiving a blood 
transfusion in the previous month; and posteriori 
(after sample extraction) exclusion criteria based 
on serum index (haemolysis, icterus and lipemia), 
presence of fibrin, inadequate barrier formation 
and insufficient sample.
In 20 healthy volunteers, we collected blood in 5.5 
mL BD Barricor™ tubes (Vacutainer®, Becton Dick-
inson, Plymouth, UK; REF 365039). In 22 different 
volunteers, we collected blood in a lithium hepa-
rin LH PST™ II 3 mL tube (Vacutainer®, Becton Dick-
inson Plymouth, UK; REF 367374). All the partici-
pants were adults randomly chosen from our clini-
cal chemistry department and gave appropriate 
informed consent. All the samples were obtained 
in our centre early in the morning (between 8 and 
9 am) and centrifuged upon arrival at our emer-
gency laboratory (no longer than 30 minutes after 
collection) for 10 minutes at 3000 g. We excluded 
two Barricor samples and one PST tube due to in-
sufficient sample. Table 1 shows groups character-
istics.
Duplicate electrolytes measurements were carried 
out in the samples almost immediately after cen-
trifugation (0 hours) and after 3, 6, 9, 12 and 15 
hours. Between this time points half of the tubes 
of each type (PST II and Barricor) were stored open 
and at room temperature (23-27 ºC controlled 
temperature) and the other half were sealed with 
Parafilm® and refrigerated (4-6 ºC controlled tem-
perature). 
The average of each pair of duplicate measure-
ments was calculated and used in statistical analy-
sis. For each group, a paired two-tailed t-test was 
performed using the values at 0h as initial paired 
values (C0) versus the values (Ct) at different time 
points (3, 6, 9, 12 and 15 hours), using software R v 
3.3.1. Statistically significant change was consid-
ered to occur when P value was less than 0.05. 
We also calculated the bias ((Ct - C0) / C0 x 100) with 
respect to the average initial value (C0) for each 
group and calculated the confidence intervals (CI) 
for small samples (calculated with the standard 
mean error and the two-tailed T-distribution with 
α = 0.05). We used SPSS v. 20 (IBM Corp., Armonk, 
USA) in this case.
There are several specifications of clinical signifi-
cance to be used in stability studies (3,4). We fol-
lowed the Spanish Society for Clinical Chemistry 
(Sociedad Española de Química Clínica, SEQC) cri-
teria of maximum allowable bias (MAB) obtained 
from reference change value formula based on 
the principle that the same sample has no biologi-
cal variation: MAB = 1.65 x CVa, where CVa is the 
analytical coefficient of variation which should be 
half the known CVi (intraindividual biological coef-
ficient of variation) or less (6). In laboratories where 
the CVa approximates the desirable one (this is our 
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situation) the tabulated MAB limits are Na+: 0.6%, 
K+: 4.0% and Cl-: 1.0%. Clinically significant deterio-
ration was considered to happen in each group 
and time when the 95% CI lied completely outside 
these specifications.
We also calculated the analytical CVa of each 
group, defined as the average of all the coefficients 
of variation between pairs of duplicate measure-
ments and compared it to the CVa obtained from 
our internal quality control in the three previous 
months (Na+: 0.45%, K+: 2.0%, Cl-: 0.7%).
Results
All the analytical CVa (Table 1) were smaller than 
the laboratory CVa, (Na+ 0.2% vs. 0.45%, K+ 0.20% 
vs. 2%, Cl- 0.25% vs. 0.7%, and similar between 
groups (different analytical series). 
Figure 1 and Table 2 show the average bias (%) 
and CIs for the results of different time points, ana-
lytes and group. In open tubes kept at room tem-
perature all the analytes exhibited statistically sig-
nificant differences since the first study time (3 
hours) both for Barricor and PST II tubes. The main 
deterioration effect in these tubes is evaporation, 
which causes approximately a 0.5-1% increase per 
hour, similar across all the electrolytes.
These changes were clinically significant at 3 hours 
in Na+ and Cl- (MABs of 0.6% and 1%, respectively) 
and at 9h in K+ (MAB of 4%).






Volunteers (N) 10 10 11 11
Tubes included for analysis (N) 10 8 11 10
Basal Na+ (mmol/L) 140.7 (1.8) 141.2 (2.0) 139.3 (4.4) 138.6 (3.4)
Basal K+ (mmol/L) 4.1 (0.5) 4.1 (0.2) 4.3 (0.7) 4.0 (0.5)
Basal Cl-  (mmol/L) 105.2 (2.5) 107.4 (4.8) 103.9 (4.9) 106.2 (4.1)
Na+ CVa (%) 0.22 0.21 0.20 0.18
K+ CVa (%) 0.13 0.20 0.21 0.22
Cl- CVa (%) 0.30 0.25 0.18 0.21
rt – room temperature. Basal concentrations of Na+, K+ and Cl- are presented as mean (standard deviation). CVa - average of 
analytical coefficients of variation between pairs of repetitions.
Figure 1. Stability curves in different groups. 
rt – room temperature.
Table 1. Group characteristics and basal electrolyte concentrations
For sealed refrigerated tubes, we observed a slight 
increase through time in Na+, statistically signifi-














































PST sealed, 4 °C
Biochemia Medica 2017;27(1):225–30  http://doi.org/10.11613/BM.2017.024 
228
Bautista Balbás LA. et al. Plasma electrolytes stability
Table 2. Relative bias with respect to basal concentrations
Relative bias (%) and P




PST II open, rt 1.13 (0.87-1.38)
*,
P < 0.001
2.77 (2.14 - 3.39)*,
P < 0.001
3.71 (3.48 - 3.94)*,
P < 0.001
4.64 (4.34 - 4.94)*,
P < 0.001
6.28 (5.92 - 6.65)*,
P < 0.001
PST II sealed, 
4 ºC




0.48 (0.08 - 0.88)†,
P = 0.026
0.50 (0.16 - 0.83)†,
P = 0.008




1.26 (0.85 - 1.67)*,
P < 0.001
2.82 (2.43 - 3.22) ,
P < 0.001
5.33 (4.59 - 6.07)*,
P < 0.001
7.95 (6.62 - 9.27)*,
P < 0.001




0.20 (- 0.31 - 0.71)
P = 0.387
0.10 (- 0.38 - 0.57)
P = 0.655
0.32 (- 0.09 - 0.73)
P = 0.112
0.73 (0.29 - 1.18)†,
P = 0.006





PST II open, rt 1.68 (1.10 - 2.26)
†,
P < 0.001
3.31 (1.81 - 4.80)†,
P < 0.001
5.31 (4.17 - 6.44)*,
P < 0.001
7.19 (6.11 - 8.27)*,
P < 0.001
9.72 (8.16 - 11.28)*,
P < 0.001
PST II sealed, 
4 ºC
1.43 (0.41 - 2.44)†,
P = 0.007
2.62 (1.24 - 4.00)†,
P = 0.002
4.09 (2.24 - 5.94)†,
P < 0.001
4.36 (2.70 - 6.02)†,
P < 0.001




1.38 (0.60 - 2.17)†,
P = 0.003
3.20 (2.39 - 4.00)†,
P < 0.001
6.30 (5.60 - 7.01)*,
P < 0.001
9.42 (8.37 - 10.47)*,
P <0 .001




0.14 (- 0.66 - 0.94)
P = 0.685
-0.15 (- 0.49 - 0.20)
P = 0.351
0.14 (- 0.19 - 0.48)
P = 0.351
0.89 (0.02 - 1.76)†,
P = 0.048





PST II open, rt 1.06 (0.67 - 1.45)
†,
P < 0.001




5.50 (4.73 - 6.26)*,
P < 0.001
7.86 (6.80 - 8.92)*,
P < 0.001
PST II sealed, 
4 ºC
0.19 (- 0.09 - 0.47)
P = 0.168
-0.23 (- 0.88 - 0.41)
P = 0.440
-0.20 (- 0.71 - 0.32)
P = 0.423
0.13 (- 0.32 - 0.58)
P = 0.496




1.57 (1.14 - 2.01)*,
P < 0.001
3.14 (2.64 - 3.65)*,
P < 0.001
6.43 (5.55 - 7.30)*,
P < 0.001
9.99 (8.64 - 11.35)*,
P < 0.001




0.11 (- 0.51 - 0.29)
P = 0.517
-0.52 (- 0.91 - 0.13)†,
P = 0.015
-0.34 (- 0.73 - 0.06)
P = 0.080
0.24 (- 0.27 - 0.76)
P = 0.316
1.84 (0.81 - 2.87)†,
P = 0.004
Relative bias is presented as mean with 95% confidence intervals. rt – room temperature. MAB - maximum allowable bias. 3 h, 6 h, 
9 h, 12 h, 15 h – 3, 6, 9, 12 and 15 hours sample storage, respectivelly. P - value of paired two-tailed t-test between the time value 
and the basal value (0 hours). P<0.05 was considered statistically significant. 
*Clinically significant (lower confidence interval outside MAB). 
†Statistically, but not clinically significant. 
cant in Barricor tubes after 12 hours. Instead, in Cl- 
we observed a slight initial decrease, followed by a 
statistically significant increase after 12 hours, not 
reaching clinical significance. In K+ we found a sta-
tistically significant increase after 3 hours in PST II 
tubes, with a lineal increase of approximately 0.4% 
per hour. However, in Barricor tubes no significant 
change was observed until 9 hours, when a statis-
tically significant increase appeared. In neither 
tube, clinical significance (4%) was reached.
Discussion
When applying, biological variation based specifi-
cations (6), we found that open tubes kept at room 
temperature showed significant losses of stability 
for electrolytes due to evaporation. Concentra-
tions increased over time being clinically signifi-
cant at 3 hours for Na+, and Cl- and at 9 hours for 
K+; this should be noted since these turnaround 
times are not unusual in many automated routine 
laboratories. In these laboratories, samples could 
wait uncapped for hours before finishing all their 
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determinations and additional tests could be re-
quested on these samples.
A recent study with open serum samples kept at 
room temperature for 16 hours found an 8.7 
mmol/L mean variation for Na+, 0.24 mmol/L for 
K+ and 6.8 mmol/L for Cl- (1). Nauck et al. found se-
rum Na+ concentration increased about 13% in 0.5 
mL samples and 3% in 2 mL samples kept opened 
at 22 ºC for 24 hours; the evaporation rate was 
smaller (5%) for 0.5 mL samples kept opened and 
refrigerated for 1 day (7). Our results are in agree-
ment with these, although with slightly higher 
evaporation in our environment.
Previous studies also corroborate our findings that 
Na+ and Cl- are clinically stable up to more than 15 
hours in capped and refrigerated plasma and se-
rum samples (3,8).
K+, a predominantly intracellular ion, is known to 
be very susceptible to interference from blood 
cells. Some authors observed variations of 13.8% 
after only 4 hours in capped whole blood samples 
kept at 4 ºC (3). In our sealed-refrigerated group, 
the PST II tube showed significant K+ increase after 
3 hours compared to Barricor tube, which remains 
statistically stable up to 12 hours. Our results are 
similar to those previously described: + 0.8% after 
2 hours and + 1.4% after 4 hours at 4 ºC in plasma 
samples (3). However, we did not find clinically sig-
nificant loss of stability (4%) in any tube up to 15 
hours. Likewise, Brandhorst found the limit of + 
5.6% for K+ was reached, according to a general-
ized model, after 10-13 hours at 4 ºC in plasma 
tubes from four different manufacturers (8).
These outcomes are in agreement with manufac-
turer’s findings that K+ is slightly more stable in 
sealed Barricor tubes than in serum SST II tubes, 
both of them improving stability compared to PST 
II tubes (5). This could be explained by the im-
proved plasma purification in Barricor tubes or in 
serum tubes; whereas in PST II tubes cells and 
platelets might be entrapped in plasma during the 
fast gel migration and barrier formation. In cell-
free serum or plasma K+ can be stable at ambient 
temperature for at least 56 hours (4,8).
Our study has some limitations. Repeated analysis 
on the same sample might decrease sample vol-
ume, which has been associated to greater sample 
evaporation (2); however, based on the Siemens 
Vista documentation, this volume should not ex-
ceed 600 µL after the 15 hours (9). We cannot ex-
clude some degree of evaporation in sealed tubes 
since those were opened during analysis (approxi-
mately 5 minutes at each time point), even though 
we re-sealed them as soon as possible. This could 
explain the slight increase in Na+ and Cl- in those 
tubes; we expected to find a decrease in these an-
alytes due to influx into erythrocytes in the con-
text of Na+/K+ ATPase failure. In addition, initial 
volumes in tubes were slightly different (3.5 vs. 5 
mL) between both types of tubes. 
Additionally, since we applied the “safest criteria” 
(only considering clinically significant when the CI 
is greater than the specification) we might have 
overestimated stability times. Similar studies in-
cluding more samples could find slightly inferior 
ones.
To conclude, evaporation is an important factor in 
electrolytes stability. In open tubes kept at room 
temperature we found clinically significant loss of 
stability at three hours for some analytes (Na+ and 
Cl-).
On usual storage conditions, sealed and refriger-
ated tubes did not show any clinically significant 
loss of stability in electrolytes up to 12 hours in 
Barricor tubes and up to 15 hours in PST tubes. We 
observed a progressive increase in K+ that was 
more pronounced in PST II tube, maybe related to 
the presence of more residual blood cells in this 
type of tube when compared to Barricor tubes.
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